| Literature DB >> 28573430 |
Dewei Chen1,2, Wenxiang Gao1,2, Shouxian Wang1,2, Bing Ni3,4, Yuqi Gao5,6.
Abstract
Pulmonary arterial hypertension (PAH) is characterized by persistent pulmonary vasoconstriction and pulmonary vascular remodeling. The pathogenic mechanisms of PAH remain to be fully clarified and measures of effective prevention are lacking. Recent studies; however, have indicated that epigenetic processes may exert pivotal influences on PAH pathogenesis. In this review, we summarize the latest research findings regarding epigenetic regulation in PAH, focusing on the roles of non-coding RNAs, histone modifications, ATP-dependent chromatin remodeling and DNA methylation, and discuss the potential of epigenetic-based therapies for PAH.Entities:
Keywords: Epigenetic; HDACs; PAECs; PASMCs; Pulmonary arterial hypertension; lncRNAs; miRNAs
Mesh:
Substances:
Year: 2017 PMID: 28573430 DOI: 10.1007/s00018-017-2551-8
Source DB: PubMed Journal: Cell Mol Life Sci ISSN: 1420-682X Impact factor: 9.261